title: Hybrid cytogenetics of chronic lymphocytic leukemia and follicular cell lymphoma in a case of non-Hodgkin's lymphoma.
authors.affiliation: Institute of Immunohematology, ICMR, KEM Hospital, Parel, Mumbai, India.
authors.forename: V
authors.initials: V
authors.lastname: Babu Rao
authors.forename: Lily
authors.initials: L
authors.lastname: Kerketta
authors.forename: M
authors.initials: M
authors.lastname: Madkaikar
authors.forename: J
authors.initials: J
authors.lastname: Farah
authors.forename: K
authors.initials: K
authors.lastname: Ghosh
mesh_terms: D015703:Antigens, CD / Q000097:blood; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D002883:Chromosomes, Human, Pair 14; D002887:Chromosomes, Human, Pair 18; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D007621:Karyotyping; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy / Q000235:genetics*; D008224:Lymphoma, Follicular / Q000188:drug therapy / Q000235:genetics*; D008228:Lymphoma, Non-Hodgkin / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D014178:Translocation, Genetic; D014314:Trisomy; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D015703:Antigens, CD; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone